



Even in the early XXI cen-
tury removal of tumors of the 
neck remains an urgent problem 
of medicine, taking into account 
the severe complications and 
high mortality [1]. 
In the total cancer incidence 
neck tumors account for about 
5 % of all cancer cases. Indicator 
of 5-year survival rate in this 
group is the lowest among of 
tumors and for this patient popu-
lation ranges from 30 to 50 % [1]. 
Surgical treatment of neck 
tumors is complex. Defeat tu-
mor structures that control such 
functions as speech, swallowing, 
taste, the blood supply to the 
brain make their removal im-
possible or lead to disability. All 
these structures can be lesions 
in malignancy and influence the 
choice of optimal treatment [2].
The tumor of carotid node 
is called carotid chemodektoma 
(chemodectoma, carotid parahan-
hlioma, carotid body tumor) that 
make up 20–30 % of paragangli-
oms in the neck [3]. This term was 
proposed in 1950 by Milligan [4].
Carotid сhemodectomy oc-
curs quite rarely, it grows slowly 
over several years. According to 
some authors, the average tumor 
growth rate is 0.83 mm/year. In 
the structure of tumor pathology, 
carotid chemodectomy is only 
0.012 % [5]. The frequency of this 
tumor in the population is 1 case 
of 1.3–2.5 million people [6].
It should be noted that most 
of the authors in their works 
demonstrate a significant contra-
diction in views on the solution 
to the problem diagnosis, treat-
ment strategy and tactics surgery 
for carotid body tumor [7]. 
At the beginning of the 90 th century 66 % removal of carot-
id hemodektoms ends only in its relapse in the 7.7–9.4 % – not 
radical surgery, and in 21.8 % of cases the tumor is considered 
unresectable [8].
Surgical treatment of neck tumors is a difficult task, due to 
the adherence of critical structures that control functions such 
as speech, swallowing, taste, blood flow to the head. Nerves, 
trunk vessels can be damaged in the tumor process and influ-
ence the choice of surgical tactics [9].
Modern treatment of the tumor process involves not 
only the removal of the tumor, but also the primary task of 
maintaining the proper quality of life and maximizing the 
preservation of functional integrity of the body and the body 
as a whole [10].
Aim. To improve the results of surgical treatment of patients 
with carotid body tumor
2. Methods
The results of the retrospec-
tive examination and treatment 
of 72 patients with tumors of 
neck vessels, who were hospi-
talized in the vascular surgery 
department of the Lviv Regional 
Hospital from 1995 to 2017 on 
the basis of medical records of 
patients, were analyzed.
Among the patients were 36 
(50 %) men and 36 (50 %) of wom-
en aged between 4 – 69 years. 
The average age of patients was 
38.7 years. Persons of working 
age were 62 (86 %) people.
In these cases the structure of 
cancer in the neck was as follows: 
benign tumor – 17 (24 %), malig-
nant tumor – 13 (18 %), carotid 
сhemodektoma (carotid body tu-
mor) – 42 (58 %).
To study the characteris-
tics of clinical course of carotid 
сhemodektoma all clinical cases 
were divided into two groups. 
The first, a core group includes 
clinical cases of carotid body tu-
mor (CBT), 42 patients. Second, 
the control group, was formed 
from clinical cases of tumor in-
vasion of another current bunch 
oncogenesis, and included 30 pa- 
tients. There were studied, com-
pared and summarized the main 
aspects of clinical groups by gen-
der, age, length of history, struc-
ture complaints and objective 
methods of research data, the 
feature of the volume and nature 
of the surgery.
In the course of the study, 
measures were taken for the safe-
ty of the patient’s health, obser-
vance of his rights, human dignity 
and moral and ethical standards 
in accordance with the princi-
ples of the Helsinki Declaration of Human Rights, the Council 
of Europe Convention on Human Rights and Biomedicine.
3. Results
In the studied groups in total 66 operations were performed.
In the main group in 1 patient in the hospital stay developed 
acute myocardial ischemia, which was the contraindication to 
the operation and the patient was transferred to a specialized 
cardiology department. 
In the second group of additional examination in 2 patients 
the presence of multiple metastases combined lymphocyte – 
phagocytic immunodeficiency in one clinical case. In 1 patient 
we diagnosed multiple metastases in the internal organs and 
locus of massive tumor in the neck, which was recognized in-
operable. Patients were discharged from the hospital for symp-
tomatic treatment in the community. Three patients refused 
surgical intervention and were under observation.
EXPERIENCE OF SURGICAL TREATMENT OF 
THE CAROTID BODY TUMOR AND TUMORS 
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Abstract: The analysis of the structure and results of surgi-
cal treatment of 72 patients who were hospitalized in the 
department of vascular surgery of Lviv regional hospital for 
the period 1995 to 2017 was realized. Among the 42 cases 
was diagnosed carotid body tumors (1-st study group) and in 
30 patients (2-nd control group) other tumors of the neck 
were detected. In the first group structure of surgery operation 
was: tumor removal and suturing the vascular wall defects – 
76 %, resection and shortening of the common carotid arte- 
ry – 21 %, expansion of the internal carotid artery – 3 %, li-
gation of the external carotid artery – 10 %, lymphadenecto- 
my – 28 %, prosthetic vascular wall – 3 %, the tumor rese- 
ction – 3 %, internal jugular vein ligation – 7 %, excision of 
fragment muscle – 3 %, nerve resection – 14 %. In the second 
group, the following surgical operations were performed: re-
moval of the tumor and suturing of the defects of the vascular 
wall – 96 %, lymphadenectomy – 48 % tumor resection – 
30 %, ligation of the internal jugular vein – 14 %, removal of the 
muscle fragment – 4 %, resection of nerves – 13 %. In group 1, 
intraoperative complications were observed in 1 (3.4 %) 
cases, which were manifested by massive bleeding from the 
tumor, requiring a repeated surgical intervention to stop 
the bleeding. Postoperative complications were observed in 
1 (3.4 %) cases when acute cerebral ischemia developed. In 
1 (3.4 %) cases, tumor recurrence was observed after 9 years. 
Clinic experience shows that surgery is an effective treat-
ment for the carotid body tumor and tumors with invasion 
into vessels of the neck, providing a low rate of complica-
tions, a full recovery or long-term remission.
Keywords: chemodectoma, carotid body tumor, paragan-
glioma, neck, carotid arteries, vessels, tumor invasion, lym-
phadenectomy, surgical treatment.
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In the group of CBT were performed 38 operations and in 
the second group 28 respectively. The average duration of the 
operation in the first group was 114 +/– 31 min. and In the 
second group of 90 +/– 26 min. The duration of postoperative 
hospital stay of patients is on average 5 days. 
In CBT group the structure of surgery operation was: tumor 
removal and suturing the vascular wall defects – 76 %, resection 
and shortening of the common carotid artery – 21 %, expansion 
of the internal carotid artery – 3 %, ligation of the external 
carotid artery – 10 %, lymphadenectomy – 28 %, prosthetic 
vascular wall – 3 %, the tumor resection – 3 %, internal jugular 
vein ligation – 7 %, excision of fragment muscle – 3 %, nerve 
resection – 14 %. 
In the second group, the following surgical operations were 
performed: removal of the tumor with vascular wall defect clo-
sure – 96 %, removal of the tumor with resection of the sterno-
clavicular muscle – 4 %, tumor removal with rotary intersection 
nerve – 13 %, removal of metastases – 30 %, excision of the tu-
mor with resection of the internal jugular vein – 14 %, removal 
of the tumor with lymphadenectomy – 48 %.
Pharmacological support of these patients included the 
antibiotics (cephalosporins), anticoagulants (Bemiparyn), the 
choice of the drug we justify by the presence of data on its an-
ticancer properties, decongestants means (L – lysine escunat).
In the first group, we observed intraoperative complications 
in 1 (3 %) patient with CBT (type I for Stamblin), which were 
manifested by massive tumor bleeding. Among the postoper-
ative complications in 1 (3 %) patient with CBT (type III for 
Stmblin), 2 days after the operation developed acute cerebral 
ischemia due to stenosis of the internal carotid artery. A repeat-
ed operation was performed: resection of the common carotid 
artery and endarterectomy of the internal carotid artery, after 
which the symptoms of the patient were completely regressed.
In 1 (3 %) case, we had a recurrence after 9 years, which 
was re-operated. In the second group, in 1 intraoperative case 
it became necessary to establish tracheostomy due to severe 
deformity of the larynx. In the same patient in the postopera-
tive period there was observed paralysis of the facial nerve and 
swallowing difficulties.
After conducting surgical intervention in the CBT group, in 
10 (25.64 %) patients we observed such neuropathies as: facial 
nerve – 2 (5.12 %), wandering and rotary nerve – 5 (12.82 %); 
tongue-throat nerve – 1 (2,56 %); transverse nerve of the neck – 
10 (25,64 %); hyoid nerve – 7 (17,95 %); Horner syndrome – 
1 (2.56 %). In this case, neuropathy has an abortive flow and 
completely regress after 6 months. after surgical intervention. 
Operative interference with carotid chemodectomy is ac-
companied by an operating blood loss in the middle of 173 ml 
versus 97 ml of blood loss in the control group. Relative risk of 
massive intraoperative bleeding in carotid chemodectomy is 
1.78 times higher than in other tumors with this localization. In 
this case, there is a direct high correlation between the size of 
the tumor and the degree of blood loss.
By 2017, the term for patient monitoring is between 1 and 
17 years. At present, we have not seen any clinical case of me-
tastasis of the СBT. In this case, patients have an active lifestyle, 
do not have professional contraindications. That is why we can 
assert that the prognosis for CBT is favorable under the condi-
tion of surgical treatment.
4. Discussion
Clinic experience shows that surgery is an effective treat-
ment for the carotid body tumor and tumors with invasion into 
vessels of the neck, providing a low rate of complications, a full 
recovery or long-term remission. 
We have shown that the technique of surgical interven-
tion developed by us provides an equivalent level of bleeding 
in comparison with the combined methods of preoperative 
embolization of feeding branches with solutions of EVOH and 
«Poloxamer-407» [11].
Traditional preoperative embolization in modern studies 
shows high efficacy, but its use is limited by the complexity of 
vascular anatomy and the presence of small feeding vessels that 
are difficult to catheterize [12]. At the same time, these tech-
niques increase the risk of thromboembolic complications in the 
cerebral pool, which are absent in our method.
Several authors note that after surgery, some patients have 
a neurological deficiency in the form of elements of the Willard 
syndrome – one-sided combined lesion of the thymus, pharyn-
geal, sublingual, extra nerve and cervical nodes of the sympa-
thetic trunk [13]. 
Our studies have shown that although neuropathy takes 
place, however, it rapidly regresses and causes the patient’s 
disability. A condition for this is the continuous control of the 
nerves in the surgical wound and the avoidance of their trauma 
when manipulating the tumor. 
Radiation and chemotherapy therapies proposed by individ-
ual authors can only be recommended to patients who have con-
traindications to surgery from other systems of the body [14]. 
In patients who underwent radiotherapy courses prior to 
surgery, we noted increased bleeding and radiation angioscle-
rosis, which complicated the operation and rehabilitation of 
patients
Surgical intervention in these patients should be per-
formed by vascular surgeons, as the surgical removal of these 
tumors, especially the carotid body tumor often requires 
resection, common carotid artery and internal carotid artery 
prostheses. 
Our study shows that tumors in the neck area are not judg-
ments for the patient. The surgical removal of such tumors, and 
in particular CBT, allows a patient to have a long life and high 
quality life. The number of complications in operations are at 
an acceptable level. 
Today, the presence of tumor invasion in the neck’s major 
vessels should not be seen as a contraindication to the operation 
and removal of the tumor. 
The use of modern vascular techniques makes it possible, if 
you do not remove the tumor completely and reduce its volume, 
to prevent the development of vascular complications, which 
greatly improves the quality of life of a patient.
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